Corona Remedies Q1 FY27 earnings call on August 3, 2026

Board & Shareholder Meetings View source PDF

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.9%1-day move

₹2089.00

prior close

—

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-2.9+0.8+0.5-1.1——————

Up moveDown movePending

AI summary

Corona Remedies will hold its Q1 FY27 post-earnings conference call on Monday, August 3, 2026 at 11:30 AM IST, organised by 360 ONE Capital Market Research. The management team led by MD and CEO Nirav Mehta, Joint MD Ankur Mehta, and CFO Bhavin Bhagat will discuss the financial results for the quarter ended June 30, 2026. The invite includes a Diamond Pass link for registration and international dial-in numbers for participants.

Likely market impact

Scheduled earnings call signals upcoming Q1 FY27 results disclosure. Investors can expect management commentary on performance and outlook.